KLBF: PT Kalbe Farma Tbk. - Summary | Jitta

PT Kalbe Farma Tbk.

IDN:KLBF

Price
Rp865.00
Loss Chance
42.9%
6.76JITTA SCORE
9.02%Over Jitta Line
Jitta Ranking
61 / 855
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (69)
Recent Business Performance (80)
Financial Strength (87)
Return to Shareholders (62)
Competitive Advantage (70)
Jitta Signs
Revenue and EarningConsistent
Recent Business PerformanceEarning Growth Last Quarter (YoY)
Debt LevelLow Long Term Debt
Dividend PayoutEvery year
Share RepurchaseEvery Year
Interest Coverage RatioVery Good
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
6.76
9.02%
4.68
45.84%
4.29
428.89%
Pharmaceuticals
4.57
50.64%
3.68
133.17%
6.20
41.96%
COMPANY DESCRIPTION
PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.